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A. Introduction
The intent of this proposal is to conduct a case control study of Parkinson's disease (PD) among Alaska Native people to determine the association of exposure to polychlorinated biphenyl (PCBs) residues, organochlorine pesticides, and methylmercury with PD. The hypothesis is that increased exposure to these compounds will be associated with an increased risk of PD. Exposure will be determined by direct measurement of serum levels, as these compounds are persistent in body tissues. In addition, lifelong exposure will be estimated by structured interviews, including a dietary history with specific attention to intake of fish, marine mammals and wild game, known sources of bioconcentration of these environmentally persistent compounds. The project is being conducted in two phases. Phase 1 was a developmental period and is complete for study conduct in Anchorage. The specific aspects of the study design were established, detailed protocols were developed, and the necessary Institutional Review Board (IRB) approvals for the research were obtained. Phase 2, conduct of the case-control study, is now in progress.
B. Body SCOPE OF WORK -PHASE 1
Task 1: Develop an ascertainment protocol using Indian Health Service (IHS) provider databases as the primary source, and identifying other possible sources of cases. Task 2: Develop methods for identifying matched controls. Accomplishments: Since the last reporting period, study personnel traveled to AK to meet with collaborating neurologists and representatives of the AK Area Institutional Review Board (IRB) to refine case and control ascertainment methods. These methods have been approved for use at the Alaska Native Medical Center (ANMC) in Anchorage.
Task 3: Develop a preliminary proposal for review by Alaska Native leaders. Subsequent detailed versions of the study protocol will be submitted for review in accordance with protocol. Accomplishments:
The study protocol, data collection instruments, and informed consents were submitted and approved by all necessary regulatory boards and the Office of Research Protections (ORP) U.S. Army Medical Research and Materiel Command (USAMRMC) for study conduct at ANMC.
Task 4:
Establishing appropriate infrastructure and personnel in Alaska. This will include a physician/neurologist, project manager, and local contacts within each tribal group. In addition, preliminary training in epidemiologic research methods may be a necessary part of a feasibility assessment. Accomplishments: Dr. Trimble, our local neurologist, has been involved with the project since its inception. In April 2007 we hired an Alaska based project manager, Amy Wiita. She completed human subjects training. She also completed training in study specific data collection methods.
Additionally, we established a comprehensive list of contacts within each tribal group.
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Task 5: Develop study instruments and a detailed protocol. Accomplishments: Drafts were completed during year 2. We developed a study protocol and study instruments for collecting detailed life histories with special focus on exposures through diet, place of residence, and occupational exposures. After receiving approval from all review boards, the ORP USAMRMC requested additional changes to the protocol. Those changes were implemented, resubmitted, and approved since the last reporting period.
Task 6: Refining the study protocol and preparing the operations manual. Accomplishments:
The study protocol was refined and approved for use in Anchorage. The operations manual has been drafted. This manual will continue to be updated as appropriate.
Task 7: IRB approval of final protocols. Accomplishments: IRB approval to recruit in the ANMC in Anchorage was achieved during this funding period, and the study has been initiated in Anchorage (see Table 1 ). There were many unexpected delays in achieving approval to conduct this work. The process required review by multiple human subjects committees prior to submission to the ORP USAMRMC. We received approval from all institutional review boards in 2007 and submitted the study protocol and materials for review by the ORP USAMRMC. The ORP USAMRMC requested changes to the protocol and consent forms. We implemented those changes, resubmitted these revised documents to the other institutional review boards and to the ORP USAMRMC. We received final documentation of approval to begin recruiting at the ANMC in Anchorage January 16, 2008 from the Alaska Area IRB.
As the study expands to other regions of Alaska, we will seek approval by native health corporations in those regions. Submissions to regional corporations are currently pending. We decided to wait until the study was initiated in Anchorage and data collection was well under way before going forward with regional submissions. Task1: Identify approximately 50 cases of PD and 150 age matched participants without PD among the Native population in Alaska. This will be accomplished by working through tribal leaders, local health care providers and local contacts at the IHS to assist with identifying the most efficient and appropriate means of identifying cases and controls. Specifically, we will request assistance with gaining access to the IHS computerized medical record, the IHS hospital discharge data system, and pharmacy databases. These databases will be used to identify individuals with a diagnosis of PD and individuals on PD medications. Potential participants will be contacted by phone and administered a PD screening instrument. Those who agree to participate and who screen positively will be examined by a trained physician who will use standardized instruments for assessing Parkinson's disease (Unified Parkinson's Disease Rating Scale, Hoehn and Yahr stage, etc.). Participants will be videotaped to allow expert confirmation of diagnosis. Control participants will be selected from the same population and similarly screened. Accomplished: Cases: We established list of 10 International Classification of Disease (ICD-9) codes related to PD. The patient database at the ANMC was electronically searched for these 10 codes. The electronic output from this search was then compared to additional information provided by the local neurologist and case manager. To date, we have generated a list of 77 potential cases of interest statewide. 10 potential cases were screened at ANMC 2 have enrollment in-progress 7 provided informed consent and enrolled in the study 1 finished all parts of the study 6 have evaluations and interviews in-progress 1 refused participation Controls: At the ANMC, we worked with staff to establish an efficient means of control recruitment. We currently recruit in common areas of the ANMC using approved pamphlets, posters, and information sheets.
16 potential controls were screened at ANMC 8 have enrollment in-progress 8 provided informed consent and enrolled in the study 8 finished all parts of the study 0 have evaluations and interviews in-progress 0 refused participation Task 2: Draw blood from cases and controls to measure levels of PCBs, organochlorine pesticides and methyl mercury. Training was conducted to ensure the proper collection, shipment, and processing of blood samples. We established a network of ANMC clinic phlebotomists to be on-call for study blood draws. After labeling, the blood samples are shipped overnight to the Parkinson's Institute laboratory for processing and storage. To date, samples from 14 subjects have been collected, shipped, and processed.
Task 3: Administer a structured interview to cases and controls to identify information important to the characterization of PCB, organochlorine pesticides and methyl mercury exposure (life time diet, occupation, place of residence, recreational activities) or identifying potential confounders (smoking cigarettes, drinking coffee, alcohol). Accomplished: Of the 15 subjects enrolled, 9 interviews have been completed and 8 are in-progress.
Task 4.
Estimate logistic regression models adjusted for age and other potential confounders to determine the odds of PD among those with high levels of PCB , organochlorine pesticides and methyl mercury exposure, individually and in combination, relative to the odds of PD among those with no or low levels of exposure the toxicants. Accomplished: This step will not be initiated until all data collection is complete.
C. Key Research Accomplishments
• Met with collaborating neurologists in AK and other local investigators to refine methods of case and control ascertainment.
• Revisions were made to study instruments, consents, and protocols to satisfy the requests of reviewers.
• Additional human subjects approval was obtained by all of the required review boards (see Table 1 ).
• Subject ascertainment, enrollment and data collection were initiated at the ANMC.
D. Reportable Outcomes
We will not have reportable outcomes until all data collection is finished statewide.
E. Conclusions
Following the completion of subject enrollment, data and sample collection, and analysis, it will be possible to draw relevant scientific conclusions.
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